Oxartis Synthetic skin

South East, United Kingdom MedTech, Materials, skin reconstruction, tissue scaffold, vascularisation

Short Summary

Oxford University developed off-the-shelf artificial dermis, for deep skin-loss wounds. Re-growing skin scarlessly will save lives and transform life-long outcomes for patients. Raising £350k pre-seed SEIS/EIS to co-fund CE/FDA regulatory testing.


  • Life-saving synthetic skin transforming life-long outcomes for patients
  • £850k grant funding to leverage £350k pre-seed investment
  • Unique patented nano-structured manufacture process, rapid & scalable
  • Experienced team assembled, already working together, top advisory board
  • Detailed plans ready to maximise efficiency of safety testing


Previous Rounds n/a
Stage Finished Product
Investor Role Monthly Involvement
Please Note: Investments of this nature carry risks to your capital as well as potential rewards. Please read our Risk Warning and Disclaimer before deciding to invest.

Sign up or log in now

Sign up now to gain full access to pitches and investor profiles




You have passed the test and you may continue your with your investment.